Glen Eagle Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.5K | Hold |
758
| – | – | ﹤0.01% | 565 |
|
|
2025
Q1 | $15.7K | Sell |
758
-11
| -1% | -$228 | ﹤0.01% | 576 |
|
|
2024
Q4 | $18.1K | Hold |
769
| – | – | ﹤0.01% | 562 |
|
|
2024
Q3 | $19.7K | Sell |
769
-27
| -3% | -$691 | ﹤0.01% | 559 |
|
|
2024
Q2 | $18.7K | Buy |
796
+23
| +3% | +$540 | ﹤0.01% | 548 |
|
|
2024
Q1 | $22.2K | Sell |
773
-19
| -2% | -$546 | ﹤0.01% | 532 |
|
|
2023
Q4 | $26K | Buy |
792
+272
| +52% | +$8.92K | 0.01% | 501 |
|
|
2023
Q3 | $14.5K | Hold |
520
| – | – | ﹤0.01% | 572 |
|
|
2023
Q2 | $17.7K | Hold |
520
| – | – | ﹤0.01% | 548 |
|
|
2023
Q1 | $15.6K | Hold |
520
| – | – | ﹤0.01% | 545 |
|
|
2022
Q4 | $14.7K | Hold |
520
| – | – | ﹤0.01% | 540 |
|
|
2022
Q3 | $17.1K | Hold |
520
| – | – | 0.01% | 510 |
|
|
2022
Q2 | $16.4K | Buy |
520
+150
| +41% | +$4.72K | ﹤0.01% | 542 |
|
|
2022
Q1 | $17K | Hold |
370
| – | – | ﹤0.01% | 537 |
|
|
2021
Q4 | $22.7K | Buy |
370
+18
| +5% | +$1.1K | 0.01% | 494 |
|
|
2021
Q3 | $26.3K | Hold |
352
| – | – | 0.01% | 500 |
|
|
2021
Q2 | $32.6K | Hold |
352
| – | – | 0.01% | 456 |
|
|
2021
Q1 | $31.2K | Buy |
+352
| New | +$31.2K | 0.01% | 430 |
|